Indications
Treatment and prophylaxis of bleeding in patients with haemophilia B (congenital factor-IX deficiency).
Composition
- Active substance
- nonacog alfa
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- BeneFIX
- Active substance
- nonacog alfa
- ATC code
- B02BD04
- Therapeutic area
- Hemophilia B
- Marketing authorisation holder
- Pfizer Europe MA EEIG
- Status
- Authorised
- EU authorisation
- 27 Aug 1997
- EMA product number